Nesher Technologies, Inc. (NTI) is a nanobiotech company which capitalizes on ground-breaking intellectual property for single molecule detection via development of ultra-sensitive diagnostic tests for detection of cancer, infectious diseases, bio-terror agents, food pathogens, etc. Nesher has exclusively licensed the Alternating Laser EXcitation (ALEX) technology from UCLA. ALEX is a SMD method based on multi-color fluorescence spectroscopy. Using this platform, Nesher is developing analytical and diagnostic kits. Applications being explored include diagnostics for cancer, Alzheimer's, Parkinson's, diabetes, asthma, infections diseases, and many others.
